# Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence

> **NCT01078792** · — · UNKNOWN · sponsor: **Hillel Yaffe Medical Center**

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- Disease Exacerbation
- Pulmonary Embolism
- Prothrombin Fragments

## Interventions

- **OTHER:** CT pulmonary angio, blood tests

## Key facts

- **NCT ID:** NCT01078792
- **Lead sponsor:** Hillel Yaffe Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01078792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01078792, "Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01078792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*